Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs

Fig. 6

NanoS100-SwIAV elicited virus-specific IL-17A+ T-helper/memory cells and CTLs in PBMCs of vaccinated pigs. Five-week-old SPF pigs were administered twice ID/IM with NanoS100-SwIAV, Nano11-SwIAV or control NanoS100 and challenged at post-prime vaccination day 35 with SwIAV H1N1-OH7. PBMCs were isolated at DPC6 and were restimulated with SwIAV H1N1-OH7 in vitro. The cells were labeled and analyzed by flow cytometry for the frequencies of IL-17A expressing CTLs, T-helper/memory cells: A Total IL-17A+ T-helper/memory cells-ID [CD3+CD4+CD8α+CD8βIL-17A+]; B IL-17A+ Central memory T-helper/memory cells-ID [CD3+CD4+CD8α+CD8βCD27+IL-17A+]; C IL-17A+ Effector memory T-helper/memory cells-ID [CD3+CD4+CD8α+CD8βCD27IL-17A+]; D Total IL-17A+ CTLs-ID [CD3+CD4CD8α+CD8β+IL-17A+]; E IL-17A+ Early Effector CTLs-ID [CD3+CD4CD8α+CD8β+CD27+IL-17A+]; F Total IL-17A+ CTLs-IM [CD3+CD4CD8α+CD8β+IL-17A+]; and G IL-17A+ Late effector CTLs-IM [CD3+CD4CD8α+CD8β+CD27IL-17A+]. Data represent the mean value of 7–8 pigs ± SEM. Statistical analysis was performed by one-way ANOVA followed by Tukey’s post-test. For head-to-head comparison between two groups, Unpaired t-test was used. Asterisk/Pound represents significant difference between indicated groups (*/♯ p < 0.05, **/♯♯ p< 0.01, and ***/♯♯♯ p < 0.001)

Back to article page